Scott Platshon is currently the Acting Chief Investment Officer at Zymeworks and serves on the boards of several biotech firms, including Zymeworks Inc., Kumquat Biosciences Inc., and Ajax Therapeutics. They have been an investor at EcoR1 Capital, LLC since 2015 and served as a financial analyst at Aquilo Partners, L.P. from 2014 to 2015. Scott holds a Bachelor of Science in Bioengineering and Biomedical Engineering from Stanford University, which they completed in 2014.
This person is not in the org chart
This person is not in any teams
This person is not in any offices